サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414250

神経膠腫治療の世界市場レポート 2024年

Glioma Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
神経膠腫治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

神経膠腫治療市場規模は近年力強く成長しています。2023年の47億米ドルから2024年にはCAGR7.1％で50億3,000万米ドルに成長します。過去の期間に見られた成長は、神経膠腫の発生率の増加、分子理解の進歩、標準治療の進化、臨床試験と研究の進展、画像診断と診断技術の強化に起因しています。

脳腫瘍および中枢神経系腫瘍の発生率の増加が予想されることから、神経膠腫治療市場の成長が期待されます。脳腫瘍や脊髄腫瘍は、脳や中枢神経系にできる異常な腫瘤です。神経膠腫治療は、脳腫瘍や脊髄がんの管理において、術後に残存するがん細胞や腫瘍の一部を除去するために利用されます。例えば、2021年8月現在、米国がん協会は、米国における脳およびその他の中枢神経系がんによる2021年の推定症例数83,570例（悪性腫瘍24,530例、非悪性腫瘍59,040例を含む）、死亡数18,600例を報告しています。したがって、脳腫瘍および脊髄腫瘍の発生率の増加は、神経膠腫治療市場成長の主要な促進要因です。

2023年の神経膠腫治療市場では北米が最大地域でした。アジア太平洋は、予測期間中に神経膠腫治療世界市場レポートにおいて最も急成長する地域となる見込みです。神経膠腫治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の神経膠腫治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 低悪性度
  • 高悪性度
  • 世界の神経膠腫治療市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 多形性膠芽腫
  • 未分化星状細胞腫
  • 未分化希突起膠腫
  • その他
  • 世界の神経膠腫治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • その他
  • 世界の神経膠腫治療市場、治療別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 手術
  • 放射線療法
  • 化学療法
  • 標的薬物療法
  • その他
  • 世界の神経膠腫治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • その他

第7章 地域および国の分析

  • 世界の神経膠腫治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の神経膠腫治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 神経膠腫治療市場の競合情勢
  • 神経膠腫治療市場の企業プロファイル
    • Merck &Co Inc.
    • Amgen Inc.
    • F Hoffmann-La Roche AG
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11760

“Glioma Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glioma treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glioma treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The glioma treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Low-Grade; High-Grade
  • 2) By Disease: Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Other Diseases
  • 3) By Route Of Administration: Oral; Parenteral; Other Routes
  • 4) By Treatment: Surgery; Radiation Therapy; Chemotherapy; Targeted Drug Therapy; Other Treatments
  • 5) By End-User: Hospitals; Specialty Clinics; Other End Users
  • Companies Mentioned: Merck & Co Inc.; Amgen Inc.; F Hoffmann-La Roche AG; Pfizer Inc.; Teva Pharmaceutical Industries Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Glioma treatment involves interventions aimed at reducing symptoms, controlling and removing tumors, and mitigating long-term damage to the brain or spinal cord. These treatments are crucial for eliminating any remaining glioma cells post-surgery.

Glioma treatment encompasses two main types, low-grade and high-grade. Low-grade gliomas are tumors that develop in the brain and typically exhibit slow growth. Diseases such as glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma, and others are addressed through various routes of administration, including oral and parenteral methods. These conditions can be treated with diverse surgeries, including radiation therapy, chemotherapy, targeted drug therapy, and others. The end users of glioma treatment include hospitals, specialty clinics, and other healthcare facilities.

The glioma treatment market research report is one of a series of new reports from The Business Research Company that provides glioma treatment market statistics, including glioma treatment industry global market size, regional shares, competitors with a glioma treatment market share, detailed glioma treatment market segments, market trends and opportunities, and any further data you may need to thrive in the glioma treatment industry. This glioma treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glioma treatment market size has grown strongly in recent years. It will grow from $4.7 billion in 2023 to $5.03 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth observed in the historical period can be ascribed to an increased incidence of gliomas, advancements in molecular understanding, the evolution of standard therapies, progress in clinical trials and research, and enhancements in imaging and diagnostic techniques.

The glioma treatment market size is expected to see strong growth in the next few years. It will grow to $6.4 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period can be ascribed to personalized therapies and biomarker discovery, advancements in immunotherapy, integration of targeted therapies, the emergence of novel therapeutic platforms, and collaborative research initiatives. Key trends expected in the forecast period include the development of blood-brain barrier-penetrating agents, the use of liquid biopsy for monitoring, an emphasis on the quality of life and supportive care, genetic and molecular subtyping, as well as increased patient advocacy and involvement.

The anticipated increase in the incidence of brain and CNS tumors is expected to drive the growth of the glioma treatment market. Brain and spinal cord tumors are abnormal masses in the brain or central nervous system. Glioma treatment is utilized in the management of brain and spinal cord cancer to eliminate any residual cancer cells or portions of the tumor post-surgery. For instance, as of August 2021, the American Cancer Society reported an estimated 83,570 cases, including 24,530 malignant tumors and 59,040 nonmalignant tumors, with 18,600 deaths from brain and other CNS cancers in the United States for the year 2021. Hence, the increasing incidence of brain and spinal cord tumors is a key driver for the growth of the glioma treatment market.

The growing demand for personalized medicine is set to propel the glioma treatment market's expansion. Personalized medicine, also known as precision medicine, represents a novel medical approach that tailors disease prevention, diagnosis, and treatment to the individual characteristics of each patient. This approach is particularly impactful in glioma treatment, shifting from a disease-centric focus to precise targeting based on unique patient characteristics. By customizing treatments to the molecular and genetic features of each patient's tumor, personalized medicine aims to enhance survival rates and maximize therapy effectiveness. For example, as of October 2022, the Personalized Medicine Coalition (PMC) projected that over 75,000 genetic testing products and 300 personalized medicines would be available for individuals with various cancers, genetic rare diseases, and a range of chronic and infectious conditions. Consequently, the rising demand for personalized medicine is a significant driver for the glioma treatment market's growth.

Innovation in product development stands out as a prominent trend in the glioma treatment market. Major players in the glioma treatment sector are incorporating novel and innovative products as part of their strategies to maintain a competitive position. An illustrative example is Daiichi Sankyo Company Limited, a Japanese pharmaceutical company, which introduced Delytact in November 2021. Delytact is a pioneering oncolytic virus therapy designed to combat brain cancer. This therapy utilizes a cancer-fighting virus with a viral genome featuring three triple mutations, enhancing selective replication in cancer cells and contributing to the treatment of malignant glioma.

Prominent companies in the glioma treatment market are concentrating on the introduction of advanced targeted therapy solutions, particularly combination medicines, to gain a competitive advantage. Combination medicines aim to offer a more effective and convenient treatment option for patients dealing with complex medical conditions such as glioma. For instance, in May 2023, Novartis AG, a Swiss pharmaceutical corporation, received approval from the U.S. Food and Drug Administration (FDA) for Tafinlar (dabrafenib) + Mekinist (trametinib) for the treatment of pediatric patients (at least one year old) with low-grade gliomas (LGGs) harboring a BRAF V600E mutation and requiring systemic therapy. This approval marks the first combination targeted medication endorsed for the treatment of BRAF V600E LGG in pediatric patients, offering a potential new standard of care therapy option. Pediatric LGG is the most prevalent type of pediatric brain cancer, with BRAF V600 mutations present in 15-25% of cases, associated with poor survival outcomes and less favorable responses to chemotherapy.

In February 2023, Kite, a global biopharmaceutical company based in the U.S., completed the acquisition of Tmunity Therapeutics for an undisclosed amount. This strategic move enhances Kite's internal capabilities in cell therapy research by incorporating additional pipeline assets. The acquisition provides access to pre-clinical and clinical programs, including an 'armored' CAR T technology platform, with the potential to enhance the anti-tumor activity of various CAR-Ts. Tmunity Therapeutics Inc., the acquired company, focuses on developing innovative products for the treatment of diffuse intrinsic pontine glioma.

Major companies operating in the glioma treatment market report are Merck & Co Inc., Amgen Inc., F Hoffmann-La Roche AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics Inc., Bristol-Myers Squibb Co., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Thermo Fisher Scientific Inc., Emcure Pharmaceuticals Ltd., Sigma-Aldrich Co., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bayer AG, Gilead Sciences Inc., Ipsen Pharma, Eisai Co. Ltd., Genentech Inc., Iovance Biotherapeutics Inc., Agios Pharmaceuticals Inc.

North America was the largest region in the glioma treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global glioma treatment market report during the forecast period. The regions covered in the glioma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the glioma treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The glioma treatment market includes revenues earned by entities by cerebral spinal fluid diversion, internal radiation therapy, and targeted therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Glioma Treatment Market Characteristics

3. Glioma Treatment Market Trends And Strategies

4. Glioma Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Glioma Treatment Market Size and Growth

  • 5.1. Global Glioma Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Glioma Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Glioma Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Glioma Treatment Market Segmentation

  • 6.1. Global Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Low-Grade
  • High-Grade
  • 6.2. Global Glioma Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Anaplastic Oligodendroglioma
  • Other Diseases
  • 6.3. Global Glioma Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Routes
  • 6.4. Global Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Targeted Drug Therapy
  • Other Treatments
  • 6.5. Global Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End Users

7. Glioma Treatment Market Regional And Country Analysis

  • 7.1. Global Glioma Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Glioma Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Glioma Treatment Market

  • 8.1. Asia-Pacific Glioma Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Glioma Treatment Market

  • 9.1. China Glioma Treatment Market Overview
  • 9.2. China Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Glioma Treatment Market

  • 10.1. India Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Glioma Treatment Market

  • 11.1. Japan Glioma Treatment Market Overview
  • 11.2. Japan Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Glioma Treatment Market

  • 12.1. Australia Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Glioma Treatment Market

  • 13.1. Indonesia Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Glioma Treatment Market

  • 14.1. South Korea Glioma Treatment Market Overview
  • 14.2. South Korea Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Glioma Treatment Market

  • 15.1. Western Europe Glioma Treatment Market Overview
  • 15.2. Western Europe Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Glioma Treatment Market

  • 16.1. UK Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Glioma Treatment Market

  • 17.1. Germany Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Glioma Treatment Market

  • 18.1. France Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Glioma Treatment Market

  • 19.1. Italy Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Glioma Treatment Market

  • 20.1. Spain Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Glioma Treatment Market

  • 21.1. Eastern Europe Glioma Treatment Market Overview
  • 21.2. Eastern Europe Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Glioma Treatment Market

  • 22.1. Russia Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Glioma Treatment Market

  • 23.1. North America Glioma Treatment Market Overview
  • 23.2. North America Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Glioma Treatment Market

  • 24.1. USA Glioma Treatment Market Overview
  • 24.2. USA Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Glioma Treatment Market

  • 25.1. Canada Glioma Treatment Market Overview
  • 25.2. Canada Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Glioma Treatment Market

  • 26.1. South America Glioma Treatment Market Overview
  • 26.2. South America Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Glioma Treatment Market

  • 27.1. Brazil Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Glioma Treatment Market

  • 28.1. Middle East Glioma Treatment Market Overview
  • 28.2. Middle East Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Glioma Treatment Market

  • 29.1. Africa Glioma Treatment Market Overview
  • 29.2. Africa Glioma Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Glioma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Glioma Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Glioma Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Glioma Treatment Market Competitive Landscape
  • 30.2. Glioma Treatment Market Company Profiles
    • 30.2.1. Merck & Co Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Amgen Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Pfizer Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Teva Pharmaceutical Industries Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Glioma Treatment Market Competitive Benchmarking

32. Global Glioma Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Glioma Treatment Market

34. Glioma Treatment Market Future Outlook and Potential Analysis

  • 34.1 Glioma Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Glioma Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Glioma Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer